Related Experiment Video
Updated: Dec 22, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups
Ozan Dikilitas1, Daniel J Schaid2, Matthew L Kosel2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Insights
Polygenic risk scores (PRSs) for coronary heart disease (CHD) show potential clinical utility across diverse populations. However, their predictive power is reduced in African ancestry individuals, underscoring the need for diverse cohorts in PRS development.
Area of Science:
- Genetics and Genomics
- Cardiovascular Disease Epidemiology
- Population Health
Background:
- Polygenic risk scores (PRSs) for coronary heart disease (CHD) are primarily developed from European ancestry (EA) cohorts.
- The predictive accuracy of these PRSs in non-European populations, such as African ancestry (AA) and Hispanic ethnicity (HE) individuals, remains uncertain.
- This uncertainty limits the equitable clinical application of PRSs for CHD risk stratification.
Purpose of the Study:
- To evaluate the association of PRSs with incident coronary heart disease (CHD) across diverse racial and ethnic groups within the U.S.
- To compare the performance of restricted and genome-wide PRSs derived from EA cohorts in EA, AA, and HE individuals.
- To identify the best performing PRS and assess its generalizability across ancestries.
Main Methods:
- Utilized the eMERGE cohort comprising 45,645 EA, 7,597 AA, and 2,493 HE individuals.
- Assessed two restricted PRSs (PRSTikkanen, PRSTada) and two genome-wide PRSs (PRSmetaGRS, PRSLDPred) developed from EA data.
- Followed participants for a median of 11.1 years to ascertain 2,652 incident CHD events, analyzing hazard and odds ratios.
Main Results:
- Genome-wide PRSs demonstrated stronger associations with CHD than restricted PRSs across all groups.
- PRSmetaGRS showed significant association with CHD in EA, HE, and AA individuals (HRs per 1 SD increase: 1.53, 1.53, and 1.27, respectively).
- Associations were comparable between EA and HE cohorts but significantly attenuated in AA individuals (pinteraction= 2.9 × 10-3).
Conclusions:
- Genome-wide PRSs, particularly PRSmetaGRS, exhibit potential clinical utility for CHD risk prediction across diverse populations.
- The predictive performance of PRSs derived from EA cohorts is significantly reduced in individuals of African ancestry.
- There is a critical need to develop and validate PRSs using diverse ancestral and ethnic cohorts to ensure equitable risk prediction.
Abstract:
Because polygenic risk scores (PRSs) for coronary heart disease (CHD) are derived from mainly European ancestry (EA) cohorts, their validity in African ancestry (AA) and Hispanic ethnicity (HE) individuals is unclear. We investigated associations of "restricted" and genome-wide PRSs with CHD in three major racial and ethnic groups in the U.S. The eMERGE cohort (mean age 48 ± 14 years, 58% female) included 45,645 EA, 7,597 AA, and 2,493 HE individuals. We assessed two restricted PRSs (PRSTikkanen and PRSTada; 28 and 50 variants, respectively) and two genome-wide PRSs (PRSmetaGRS and PRSLDPred; 1.7 M and 6.6 M variants, respectively) derived from EA cohorts. Over a median follow-up of 11.1 years, 2,652 incident CHD events occurred. Hazard and odds ratios for the association of PRSs with CHD were similar in EA and HE cohorts but lower in AA cohorts. Genome-wide PRSs were more strongly associated with CHD than restricted PRSs were. PRSmetaGRS, the best performing PRS, was associated with CHD in all three cohorts; hazard ratios (95% CI) per 1 SD increase were 1.53 (1.46-1.60), 1.53 (1.23-1.90), and 1.27 (1.13-1.43) for incident CHD in EA, HE, and AA individuals, respectively. The hazard ratios were comparable in the EA and HE cohorts (pinteraction = 0.77) but were significantly attenuated in AA individuals (pinteraction= 2.9 × 10-3). These results highlight the potential clinical utility of PRSs for CHD as well as the need to assemble diverse cohorts to generate ancestry- and ethnicity PRSs.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Polygenic Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Stereotypes, Prejudice, and Discrimination